Last reviewed · How we verify

NCT03109132

Comfort Check of CO2 Monitoring Cannulas With Oxygen Delivery

Completed NA Last updated 8 December 2017
What this trial tests

NA trial testing Oridion Smart CapnoLine® H Plus with Wedge cannula in Wearing Comfort in 60 participants. Completed in 30 August 2017.

Timeline
23 April 2017
Primary endpoint
30 August 2017
30 August 2017

Quick facts

Lead sponsorMedtronic - MITG
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designcrossover
Maskingtriple
Primary purposedevice feasibility
Enrollment60
Start date23 April 2017
Primary completion30 August 2017
Estimated completion30 August 2017
Sites1 location across Israel

Drugs / interventions tested

Conditions studied

Sponsor

Medtronic - MITG — full company profile →

Who can join

Adults 50 to 85, any sex, with Wearing Comfort. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this test is to evaluate the comfort level of several model configurations of the Smart CapnoLine plus cannula The test focuses on the comfort / discomfort generated by the device, mainly due to tubes around the ears and on the face skin, the cannula itself (especially in the nostrils and the mouth surrounding) and the smell.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Medtronic - MITG trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03109132.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing